|
G |
Ace |
angiotensin I converting enzyme |
decreases activity |
ISO |
bioallethrin results in decreased activity of ACE protein |
CTD |
PMID:32097678 |
|
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
ISO |
Vitamin E inhibits the reaction [bioallethrin results in increased expression of BAX protein] |
CTD |
PMID:35511042 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Casp3 |
caspase 3 |
increases cleavage multiple interactions |
ISO |
bioallethrin results in increased cleavage of CASP3 protein Vitamin E inhibits the reaction [bioallethrin results in increased cleavage of CASP3 protein] |
CTD |
PMID:35511042 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases cleavage |
ISO |
Vitamin E inhibits the reaction [bioallethrin results in increased cleavage of CASP9 protein] |
CTD |
PMID:35511042 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
decreases activity |
ISO |
bioallethrin results in decreased activity of CAT protein |
CTD |
PMID:32097678 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ces1d |
carboxylesterase 1D |
increases metabolic processing |
ISO |
CES1 protein results in increased metabolism of bioallethrin |
CTD |
PMID:19249324 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Chrm4 |
cholinergic receptor, muscarinic 4 |
multiple interactions |
ISO |
[DDT co-treated with bioallethrin] results in increased expression of CHRM4 mRNA |
CTD |
PMID:10192214 |
|
NCBI chr 3:77,893,425...77,901,166
Ensembl chr 3:77,893,425...77,901,159
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases metabolic processing increases expression |
ISO |
CYP3A4 protein results in increased metabolism of bioallethrin bioallethrin results in increased expression of CYP3A4 mRNA |
CTD |
PMID:19249324 |
|
NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Glo1 |
glyoxalase 1 |
increases activity |
ISO |
bioallethrin results in increased activity of GLO1 protein |
CTD |
PMID:32097678 |
|
NCBI chr20:8,663,617...8,681,661
Ensembl chr20:8,662,801...8,681,649
|
|
G |
Gsr |
glutathione-disulfide reductase |
decreases activity |
ISO |
bioallethrin results in decreased activity of GSR protein |
CTD |
PMID:32097678 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions |
ISO |
bioallethrin results in increased expression of HMOX1 protein [Vitamin E co-treated with bioallethrin] results in increased expression of HMOX1 protein |
CTD |
PMID:35511042 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Ifng |
interferon gamma |
multiple interactions decreases expression affects expression |
ISO |
[bioallethrin co-treated with Piperonyl Butoxide] results in increased expression of IFNG protein bioallethrin results in decreased expression of IFNG mRNA bioallethrin affects the expression of IFNG protein |
CTD |
PMID:9860237 PMID:10414782 PMID:12755381 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il4 |
interleukin 4 |
multiple interactions affects expression |
ISO |
[bioallethrin co-treated with Piperonyl Butoxide] results in increased expression of IL4 protein bioallethrin affects the expression of IL4 protein |
CTD |
PMID:9860237 PMID:10414782 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
increases expression multiple interactions |
ISO |
bioallethrin results in increased expression of NFE2L2 protein Vitamin E inhibits the reaction [bioallethrin results in increased expression of NFE2L2 protein] |
CTD |
PMID:35511042 |
|
NCBI chr 3:60,594,239...60,621,785
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression multiple interactions |
ISO |
bioallethrin results in increased expression of NQO1 protein [Vitamin E co-treated with bioallethrin] results in increased expression of NQO1 protein |
CTD |
PMID:35511042 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases activity |
ISO EXP |
bioallethrin results in increased activity of NR1I2 protein |
CTD |
PMID:19249324 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Scn10a |
sodium voltage-gated channel alpha subunit 10 |
affects activity |
EXP |
bioallethrin affects the activity of SCN10A protein |
CTD |
PMID:19766671 |
|
NCBI chr 8:119,350,723...119,462,882
Ensembl chr 8:119,350,724...119,462,614
|
|
G |
Scn1b |
sodium voltage-gated channel beta subunit 1 |
multiple interactions |
EXP |
bioallethrin affects the reaction [[SCN2B protein co-treated with SCN1B protein co-treated with SCN8A protein mutant form] results in increased transport of Sodium] |
CTD |
PMID:22465659 |
|
NCBI chr 1:86,353,917...86,363,836
Ensembl chr 1:86,353,917...86,363,739
|
|
G |
Scn2b |
sodium voltage-gated channel beta subunit 2 |
multiple interactions |
EXP |
bioallethrin affects the reaction [[SCN2B protein co-treated with SCN1B protein co-treated with SCN8A protein mutant form] results in increased transport of Sodium] |
CTD |
PMID:22465659 |
|
NCBI chr 8:45,425,629...45,437,765
Ensembl chr 8:45,425,629...45,437,765
|
|
G |
Scn8a |
sodium voltage-gated channel alpha subunit 8 |
multiple interactions |
EXP |
bioallethrin affects the reaction [[SCN2B protein co-treated with SCN1B protein co-treated with SCN8A protein mutant form] results in increased transport of Sodium] |
CTD |
PMID:22465659 |
|
NCBI chr 7:131,982,152...132,156,075
Ensembl chr 7:131,982,480...132,151,292
|
|
|
G |
Pomc |
proopiomelanocortin |
multiple interactions |
EXP |
[2,5-dihydro-2,4,5-trimethylthiazoline co-treated with 3-hexen-1-ol co-treated with 2-hexenal] results in decreased expression of POMC protein; [3-hexen-1-ol co-treated with 2-hexenal] inhibits the reaction [2,5-dihydro-2,4,5-trimethylthiazoline results in decreased expression of POMC protein]; [3-hexen-1-ol co-treated with 2-hexenal] results in decreased expression of POMC |
CTD |
PMID:19103229 PMID:21515296 |
|
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
|
|
|
G |
Pafah1b1 |
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 |
increases expression multiple interactions |
EXP |
Castor Oil results in increased expression of PAFAH1B1 protein isosorbide-5-mononitrate inhibits the reaction [Castor Oil results in increased expression of PAFAH1B1 protein] |
CTD |
PMID:1354728 PMID:2743081 PMID:8738301 |
|
NCBI chr10:59,533,042...59,591,808
Ensembl chr10:59,534,117...59,591,808
|
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
drimenol results in increased expression of BAX protein |
CTD |
PMID:30935903 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
ISO |
drimenol results in decreased expression of BCL2 protein |
CTD |
PMID:30935903 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Casp3 |
caspase 3 |
increases activity |
ISO |
drimenol results in increased activity of CASP3 protein |
CTD |
PMID:30935903 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
increases cleavage |
ISO |
drimenol results in increased cleavage of CASP9 protein |
CTD |
PMID:30935903 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
|
G |
Cat |
catalase |
decreases expression |
EXP |
imiprothrin results in decreased expression of CAT protein |
CTD |
PMID:33638779 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases expression |
EXP |
imiprothrin results in increased expression of CYP1A2 mRNA |
CTD |
PMID:33638779 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases expression |
EXP |
imiprothrin results in increased expression of GPT protein |
CTD |
PMID:33638779 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
affects expression |
ISO |
Pyrethrins affects the expression of BAX protein |
CTD |
PMID:27939866 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
affects expression |
ISO |
Pyrethrins affects the expression of BCL2 protein |
CTD |
PMID:27939866 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions |
ISO |
Pyrethrins inhibits the reaction [Potassium results in increased expression of BDNF mRNA] |
CTD |
PMID:15527870 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Casp3 |
caspase 3 |
increases activity |
ISO |
Pyrethrins results in increased activity of CASP3 protein |
CTD |
PMID:27939866 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
increases activity |
ISO |
Pyrethrins results in increased activity of CASP9 protein |
CTD |
PMID:27939866 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
increases activity |
EXP |
Pyrethrins results in increased activity of CAT protein |
CTD |
PMID:35678313 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
increases expression |
EXP |
Pyrethrins results in increased expression of CYP2B1 mRNA |
CTD |
PMID:18022748 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
increases expression |
EXP |
Pyrethrins results in increased expression of CYP2B2 mRNA |
CTD |
PMID:18022748 |
|
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases expression |
ISO |
Pyrethrins results in increased expression of CYP2B6 mRNA |
CTD |
PMID:18022748 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases expression |
ISO |
Pyrethrins results in increased expression of CYP3A4 mRNA |
CTD |
PMID:18022748 |
|
NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
Pyrethrins inhibits the reaction [Potassium results in increased expression of FOS mRNA] |
CTD |
PMID:15527870 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
affects activity |
EXP |
Pyrethrins affects the activity of GPT protein |
CTD |
PMID:35678313 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO |
Pyrethrins binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:21115097 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage |
ISO |
Pyrethrins results in increased cleavage of PARP1 protein |
CTD |
PMID:27939866 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions |
ISO |
Pyrethrins binds to and results in increased activity of PPARA protein |
CTD |
PMID:17084873 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
affects binding |
ISO |
ricinoleic acid analog binds to CNR1 protein |
CTD |
PMID:16406364 |
|
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
|
|
G |
Cnr2 |
cannabinoid receptor 2 |
multiple interactions |
ISO |
ricinoleic acid analog binds to and affects the activity of CNR2 protein |
CTD |
PMID:16406364 |
|
NCBI chr 5:148,125,222...148,151,548
Ensembl chr 5:148,125,604...148,151,548
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
ISO |
ricinoleic acid inhibits the reaction [IL4 protein results in increased expression of VCAM1 protein] |
CTD |
PMID:7544037 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Ptgds |
prostaglandin D2 synthase |
affects binding |
ISO |
ricinoleic acid binds to PTGDS protein |
CTD |
PMID:26456343 |
|
NCBI chr 3:8,281,899...8,284,833
Ensembl chr 3:8,281,899...8,284,833
|
|
G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
multiple interactions |
ISO |
ricinoleic acid analog binds to and affects the activity of TRPV1 protein |
CTD |
PMID:16406364 |
|
NCBI chr10:57,851,428...57,876,513
Ensembl chr10:57,851,428...57,876,513
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
multiple interactions |
ISO |
ricinoleic acid inhibits the reaction [IL4 protein results in increased expression of VCAM1 protein] |
CTD |
PMID:7544037 |
|
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
|
|